MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Building a Data Base for Automatic Speech Recognition in Parkinson’s disease (PD)

L. Ramig, R. Macdonald, P. Jiang, H. Hodges, J. Spielman, O. Reed, E. Nauman, C. Bergey, J. Cattiau (New York, USA)

Meeting: MDS Virtual Congress 2021

Abstract Number: 1304

Keywords: Dysarthria, Parkinson’s

Category: Technology

Objective:
Describe the rationale and process for acquiring speech data to contribute to increasing accessibility to speech recognition for patients with PD.

Background:

Disordered speech and voice may limit access to everyday voice activated devices (e.g., mobile phones, computers). These devices have automatic speech recognition (ASR) systems that have been trained on non-disordered speech. This makes it frustrating for individuals with speech disorders such as those accompanying PD to utilize these devices. Project Euphonia is an initiative by Google to make speech technology more accessible to individuals with non-standard speech. The first step in this process is to gather large numbers of speech samples from disordered speakers in order to train speech recognition systems. This paper reports initial work to collect speech data from individuals with PD in collaboration with a team including research scientists, software engineers, experts in speech recognition algorithms, designers and product managers.

Method: The first step in this process is to teach speech recognition algorithms to understand disordered speech. While there is a vast literature on automatic speech recognition algorithms, to teach these algorithms to understand disordered speech, they need sufficient speech samples from disordered speakers. Because of our over twenty years of research on speech and voice in PD (e.g., Ramig et al., 1995; Ramig et al., 2001a, 2001b; Ramig et al, 2018), including years of gathering acoustic data on patients with PD as well as having access to a large PD community, our research team at LSVT Global was invited to collaborate on Project Euphonia.

Results: After a series of pilot studies, procedures were established to optimize successful data collection supported by speech therapy mentors. Screening procedures were established for technology, cognitive, motor challenges and potential home support. Recruiting was expanded to include eight major Parkinson’s disease organizations. By completion of the final pilot study, 75,356 phrases were collected from patients with PD, MSA, CBD and PSP. Outcomes of the speech recognition data analysis will be reported.

Conclusion: A feasible data collection procedure has been established and the project will scale up to include larger numbers of patients, disorders and dialects.
Portions of this project were presented as part of a Virtual ASHA Mini Convention, November, 2020.

References: Ramig, L. O., Countryman, S., Thompson, L. L., Horii, Y. (1995). A comparison of two forms of intensive speech treatment for Parkinson’s disease. Journal of Speech and Hearing Research, 38, 1232-1251. Ramig, L. O., Sapir, S., Countryman, S., et al. (2001a). Intensive voice treatment (LSVT®) for individuals with Parkinson’s disease: a two-year follow-up. Journal of Neurology, Neurosurgery, and Psychiatry, 71, 493-498. Ramig, L. O., Sapir, S., Fox, C. M., & Countryman, S. (2001b). Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson’s disease: a comparison with untreated patients and normal age-matched controls. Movement Disorders, 16, 79-83. Ramig, L., Halpern, A., Spielman, J., Fox, C., & Freeman, K. (2018). Speech treatment in Parkinson’s disease: Randomized controlled trial (RCT). Movement Disorders, 33(11), 1777-1791.

To cite this abstract in AMA style:

L. Ramig, R. Macdonald, P. Jiang, H. Hodges, J. Spielman, O. Reed, E. Nauman, C. Bergey, J. Cattiau. Building a Data Base for Automatic Speech Recognition in Parkinson’s disease (PD) [abstract]. Mov Disord. 2021; 36 (suppl 1). https://www.mdsabstracts.org/abstract/building-a-data-base-for-automatic-speech-recognition-in-parkinsons-disease-pd/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to MDS Virtual Congress 2021

MDS Abstracts - https://www.mdsabstracts.org/abstract/building-a-data-base-for-automatic-speech-recognition-in-parkinsons-disease-pd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley